"In other words...Leronlimab is at LEAST 25 times better...very long term.
Now that... is a staggering statistic...and it will only grow with time.
We beat a Platform drug...that wasn't really a platform drug after all.
(11)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-